Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer

Gynecologic Oncology

Volumn 112, Issue 3, 2009, Pages 537-542

  Jongen, Vincent ^a   Briët, Justine ^a   de Jong, Renske ^a   ten Hoor, Klaske ^a   Boezen, Marike ^a   van der Zee, Ate ^a   Nijman, Hans ^a   Hollema, Harry ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Endometrioid endometrial cancer; Estrogen receptor; Progesterone receptor; Tissue microarray

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENT CANCER; TISSUE MICROARRAY; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; COHORT STUDIES; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RECEPTORS, PROGESTERONE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 60449115147     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.10.032     Document Type: Article

References (25)

1. Sherman M.E. Theories of endometrial carcinogenesis: a multidisciplinary approach. Modern Pathol 13 (2000) 295-308
2. Creutzberg C.L., van Putten W.L., Koper P.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Postoperative radiation therapy in endometrial carcinoma. Lancet 355 (2000) 1404-1411
3. Keys H.M., Roberts J.A., and Brunetto V.L. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol 92 (2004) 744-751
4. Kodama J., Seki N., and Hiramatsu Y. Chemotherapy for high-risk early-stage endometrial cancer. Curr Opin Obstet Gynecol. 19 1 (2007) 42-47
5. Gehrig P.A., Van Le L., Olatidoye B., and Geradts. Estrogen receptor status, determined by immunohistochemistry, as a predictor of the recurrence of stage I endometrial carcinoma. J Cancer 86 (1999) 2083-2089
6. Jeon Y.T., Part I.A., Kim Y.B., Kim J.W., Park N.H., and Kang S.B. Steroid receptor expressions in endometrial cancer: clinical significance and epidemiological implication. Cancer Lett 239 (2006) 198-204
7. Fujimoto J., Sakaguchi H., Aoki I., Toyoki H., and Tamaya T. Clinical implications of the expression of estrogen-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers. Oncol 62 (2002) 269-277
8. Mylonas I., Jeschke U., Shabani N., Kuhn C., Kriegel S., Kupka M.S., et al. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR). Anticancer Res 25 (2005) 1679-1686
9. Miyamoto T., Watanabe J., Hata H., Jobo T., Kawaguchi M., Hattori M., et al. Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma. J Steroid Biochem Molec Biol 92 (2004) 111-118
10. Hanekamp E.E., Gielen S.C.J.P., Smid-Koopman E., Kuhne L.C.M., de Ruiter P.E., Chadha-Ajwani S., et al. Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer. Clin Cancer Res 9 (2003) 4190-4199
11. Arnett-Mansfield R.L., deFazio A., Wain G.V., Jaworski R.C., Byth K., Mote P.A., et al. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Cancer Res 61 (2001) 4576-4582
12. Hirai M., Hirono M., Oosaki T., Hayashi Y., Yoshihara T., and Matsuzaki O. Prognostic factors relating to survival in uterine endometrioid carcinoma. Int J Gynaecol Obstet 66 (1999) 155-162
13. Steiner E., Eicher O., Sagemuller J., Schmidt M., Pilch H., Tanner B., et al. Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int J Gynecologic Cancer 13 (2003) 197-203
14. Oreskovic S., Babic D., Kalafatic D., Barisic D., and Beketic-Oreskovic L. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma. Gynecol Oncol 93 (2004) 34-40
15. Briet J.M., Hollema H., Reesink N., Aalders J.G., Mourits M., ten Hoor K.A., et al. Lymphvascular space involvment: an independent prognostic factor in endometrial cancer. Gyn Oncol 96 (2005) 799-804
16. Hoos A., and Cordon-Cardo C. Tissue microarray profiling of cancer specimens and cell-lines: opportunities and limitations. Lab Invest 81 (2001) 1331-1338
17. Hendriks Y., Franken P., Diersen J.W., de Leeuw W., Wijnen J., Dreef E., et al. Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. Am J Pathol 162 (2003) 469-477
18. Kallioniemi O.P., Wagner U., Kononen J., and Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 10 (2001) 657-662
19. Nijhuis E.R., Nijman H.W., Oien K.A., Bell A., ten Hoor K.A., Reesink-Peters N., et al. Loss of MSH2 protein expression is a risk factor in early stage cervical cancer. J Clin Pathol 60 (2007) 824-830
20. Leitao M.M., Soslow R.A., Nonaka D., Olshen A.B., Aghajanian C., Sabbatini P., et al. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 101 (2004) 1455-1462
21. Utsunomiya H., Suzuki T., Harada N., Ito K., and Matsuzaki S. Analysis of estrogen receptor alpha and beta in endometrial carcinomas: correlation with ERbeta and clinicopathologic findings in 45 cases. Int J Gynecol Pathol 19 (2000) 335-341
22. Hu K., Zhong G., and He F. Expression of estrogen receptors ER alpha and ER beta in endometrial hyperplasia and adenocarcinoma. In J Gynecol Cancer 15 (2005) 537-541
23. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors and. Endocrinol 138 (1997) 863-870
24. Takama F., Kanuma T., Wang D., Kagami I., and Mizunuma H. Oestrogen receptor beta expression and depth of myometrial invasion in human endometrial cancer. Br J Cancer 84 (2001) 545-549
25. Shabani N., Kuhn C., Kunze S., Schulze S., Mayr D., Dian D., et al. Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas. Eur J Cancer 43 (2007) 2434-2444